Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint.
Mistry HB, MacCallum DE, Jackson RC, Chaplain MA, Davidson FA. Mistry HB, et al. Front Biosci (Landmark Ed). 2010 Jan 1;15:249-58. doi: 10.2741/3619. Front Biosci (Landmark Ed). 2010. PMID: 20036819
Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma.
Mistry HB, Orrell D, Eftimie R. Mistry HB, et al. Cancer Chemother Pharmacol. 2018 Feb;81(2):325-332. doi: 10.1007/s00280-017-3486-3. Epub 2017 Dec 8. Cancer Chemother Pharmacol. 2018. PMID: 29222604 Free PMC article. Clinical Trial.
Modeling the temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase.
Mistry HB, MacCallum DE, Jackson RC, Chaplain MA, Davidson FA. Mistry HB, et al. Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20215-20. doi: 10.1073/pnas.0810706106. Epub 2008 Dec 17. Proc Natl Acad Sci U S A. 2008. PMID: 19091947 Free PMC article.
The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Shawkat E, Mistry H, Chmiel C, Webster L, Chappell L, Johnstone ED, Myers JE. Shawkat E, et al. Pregnancy Hypertens. 2018 Jan;11:92-98. doi: 10.1016/j.preghy.2017.12.007. Epub 2018 Jan 2. Pregnancy Hypertens. 2018. PMID: 29523282
Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data.
Wendling T, Mistry H, Ogungbenro K, Aarons L. Wendling T, et al. Cancer Chemother Pharmacol. 2016 May;77(5):927-38. doi: 10.1007/s00280-016-2994-x. Epub 2016 Mar 3. Cancer Chemother Pharmacol. 2016. PMID: 26940939 Free PMC article.
Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics.
Mistry HB, Helmlinger G, Al-Huniti N, Vishwanathan K, Yates J. Mistry HB, et al. Cancer Chemother Pharmacol. 2019 Jul;84(1):51-60. doi: 10.1007/s00280-019-03840-3. Epub 2019 Apr 24. Cancer Chemother Pharmacol. 2019. PMID: 31020352 Free PMC article.
A simple model of a growing tumour.
Orrell D, Mistry HB. Orrell D, et al. Among authors: mistry hb. PeerJ. 2019 May 31;7:e6983. doi: 10.7717/peerj.6983. eCollection 2019. PeerJ. 2019. PMID: 31183252 Free PMC article.
A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment.
Mistry HB, Davies MR, Di Veroli GY. Mistry HB, et al. Front Pharmacol. 2015 Mar 24;6:59. doi: 10.3389/fphar.2015.00059. eCollection 2015. Front Pharmacol. 2015. PMID: 25852560 Free PMC article.
22 results
Jump to page
Feedback